Hong Xing
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hong Xing has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Xiaopeng Chen
Institute of Traditional Chinese Medicine Tianjin University of Traditional Chinese Medicine Tianjin China
3 shared publications - Chunxia Li
State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese, Tianjin 301617, China
2 shared publications - Jing Liu
State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese, Tianjin 301617, China
2 shared publications - Qiaoyu He
State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese, Tianjin 301617, China
2 shared publications Er‐Wei Liu
Institute of Traditional Chinese Medicine Tianjin University of Traditional Chinese Medicine Tianjin China
1 shared publicationHong Liu
State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese, Tianjin 301617, China
1 shared publication
Latest Publications
- 16 May 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (7) , e70112
Gut Microbiota Combined With Metabolomics to Reveal the Mechanism of Tang Wang Ming Mu Granule in the Treatment of Diabetic Retinopathy in Mice
Diabetes retinopathy (DR) is one of the serious complications of diabetes. Clinical practice has proved that Tang Wang Ming Mu Granule (TWMM) can improve symptoms of DR patients. The mechanism of TWMM in treating DR in mice was studied, combining gut microbiota with metabolomics. A high‐fat and high‐sugar diet combined with streptozotocin (STZ) injection was used to create a mouse model of DR. The C57BL6/J wild‐type mice were divided into five groups, including normal control, DR model, TWMM (2.7 and 10.8 g/kg) treatment, and the positive control treatment groups. Based on urine metabolomics and 16S rDNA sequencing of fecal samples, the effects of TWMM on host metabolism and intestinal microbiota were studied. The results showed that TWMM reverses the disordered intestinal flora to normal. In addition, the pathway prediction of intestinal microorganisms was related to the metabolic pathways. Meanwhile, the metabolomics analysis found that the differential metabolites were mainly concentrated in amino acids and their metabolites, carbohydrates, and their metabolites. The Shigellosis pathway attracted attention, and Shigella shows good indication in the treatment. The research provides a method for metabolic disease study with gut microbiota combined with metabolomics and treatment targets and pathways of DR.
- 16 May 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (7) , e70112
Gut Microbiota Combined With Metabolomics to Reveal the Mechanism of Tang Wang Ming Mu Granule in the Treatment of Diabetic Retinopathy in Mice
Diabetes retinopathy (DR) is one of the serious complications of diabetes. Clinical practice has proved that Tang Wang Ming Mu Granule (TWMM) can improve symptoms of DR patients. The mechanism of TWMM in treating DR in mice was studied, combining gut microbiota with metabolomics. A high‐fat and high‐sugar diet combined with streptozotocin (STZ) injection was used to create a mouse model of DR. The C57BL6/J wild‐type mice were divided into five groups, including normal control, DR model, TWMM (2.7 and 10.8 g/kg) treatment, and the positive control treatment groups. Based on urine metabolomics and 16S rDNA sequencing of fecal samples, the effects of TWMM on host metabolism and intestinal microbiota were studied. The results showed that TWMM reverses the disordered intestinal flora to normal. In addition, the pathway prediction of intestinal microorganisms was related to the metabolic pathways. Meanwhile, the metabolomics analysis found that the differential metabolites were mainly concentrated in amino acids and their metabolites, carbohydrates, and their metabolites. The Shigellosis pathway attracted attention, and Shigella shows good indication in the treatment. The research provides a method for metabolic disease study with gut microbiota combined with metabolomics and treatment targets and pathways of DR.
- Open Access
- 27 September 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 2394398
Network Toxicology Guided Mechanism Study on the Association between Thyroid Function and Exposures to Polychlorinated Biphenyls Mixture
Polychlorinated biphenyls (PCBs) are persistent and highly toxic pollutants, which can accumulate in organisms and produce toxic effects, especially damaging the function of thyroid hormones. So far, the molecular mechanism of PCBs mixture and their metabolites interfering with thyroid hormones has not been studied thoroughly except for individual compounds. In this study, PubMed, Web of Science, and STITCH databases were used to search PCBs and their corresponding target proteins. The intersection of PCBs and thyroid hormone dysfunction target proteins was obtained from GeneCards. The “compounds‐targets‐pathways” network was constructed by Cytoscape software. And KEGG and Go analyses were performed for key targets. Finally, molecular docking was used to verify the binding effect. Four major active components, five key targets, and 10 kernel pathways were successfully screened by constructing the network. Functional enrichment analysis showed that the interference was mediated by cancer, proteoglycans, PI3K‐Akt, thyroid hormone, and FoxO signaling pathways. The molecular docking results showed that the binding energies were less than ‐5 kcal·mol-1. PCBs and their metabolites may act on the key targets of MAPK3, MAPK1, RXRA, PIK3R1, and TP53. The toxic effect of sulfated and methyl sulfone PCBs is greater. The method of screening targets based on the simultaneous action of multiple PCBs can provide a reference for other research. The targets were not found in previous metabolite toxicity studies. It also provides a bridge for the toxic effects and experimental research of PCBs and their metabolites in the future.
- 27 September 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 2394398
Open AccessNetwork Toxicology Guided Mechanism Study on the Association between Thyroid Function and Exposures to Polychlorinated Biphenyls Mixture
Polychlorinated biphenyls (PCBs) are persistent and highly toxic pollutants, which can accumulate in organisms and produce toxic effects, especially damaging the function of thyroid hormones. So far, the molecular mechanism of PCBs mixture and their metabolites interfering with thyroid hormones has not been studied thoroughly except for individual compounds. In this study, PubMed, Web of Science, and STITCH databases were used to search PCBs and their corresponding target proteins. The intersection of PCBs and thyroid hormone dysfunction target proteins was obtained from GeneCards. The “compounds‐targets‐pathways” network was constructed by Cytoscape software. And KEGG and Go analyses were performed for key targets. Finally, molecular docking was used to verify the binding effect. Four major active components, five key targets, and 10 kernel pathways were successfully screened by constructing the network. Functional enrichment analysis showed that the interference was mediated by cancer, proteoglycans, PI3K‐Akt, thyroid hormone, and FoxO signaling pathways. The molecular docking results showed that the binding energies were less than ‐5 kcal·mol-1. PCBs and their metabolites may act on the key targets of MAPK3, MAPK1, RXRA, PIK3R1, and TP53. The toxic effect of sulfated and methyl sulfone PCBs is greater. The method of screening targets based on the simultaneous action of multiple PCBs can provide a reference for other research. The targets were not found in previous metabolite toxicity studies. It also provides a bridge for the toxic effects and experimental research of PCBs and their metabolites in the future.
- Open Access
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
Combining Network Pharmacology with Molecular Docking for Mechanistic Research on Thyroid Dysfunction Caused by Polybrominated Diphenyl Ethers and Their Metabolites
Network pharmacology was used to illuminate the targets and pathways of polybrominated diphenyl ethers (PBDEs) causing thyroid dysfunction. A protein‐protein interaction (PPI) network was constructed. Molecular docking was applied to analyze PBDEs and key targets according to the network pharmacology results. A total of 247 targets were found to be related to 16 PBDEs. Ten key targets with direct action were identified, including the top five PIK3R1, MAPK1, SRC, RXRA, and TP53. Gene Ontology (GO) functional enrichment analysis identified 75 biological items. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis identified 62 pathways mainly related to the regulation of the thyroid hormone signaling pathway, MAPK signaling pathway, PI3K‐Akt signaling, pathways in cancer, proteoglycans in cancer, progesterone‐mediated oocyte maturation, and others. The molecular docking results showed that BDE‐99, BDE‐153, 5‐OH‐BDE47, 5 ′‐OH‐BDE99, 5‐BDE47 sulfate, and 5 ′‐BDE99 sulfate have a good binding effect with the kernel targets. PBDEs could interfere with the thyroid hormone endocrine through multiple targets and biological pathways, and metabolites demonstrated stronger effects than the prototypes. This research provides a basis for further research on the toxicological effects and molecular mechanisms of PBDEs and their metabolites. Furthermore, the application of network pharmacology to the study of the toxicity mechanisms of environmental pollutants provides a new methodology for environmental toxicology.
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
Open AccessCombining Network Pharmacology with Molecular Docking for Mechanistic Research on Thyroid Dysfunction Caused by Polybrominated Diphenyl Ethers and Their Metabolites
Network pharmacology was used to illuminate the targets and pathways of polybrominated diphenyl ethers (PBDEs) causing thyroid dysfunction. A protein‐protein interaction (PPI) network was constructed. Molecular docking was applied to analyze PBDEs and key targets according to the network pharmacology results. A total of 247 targets were found to be related to 16 PBDEs. Ten key targets with direct action were identified, including the top five PIK3R1, MAPK1, SRC, RXRA, and TP53. Gene Ontology (GO) functional enrichment analysis identified 75 biological items. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis identified 62 pathways mainly related to the regulation of the thyroid hormone signaling pathway, MAPK signaling pathway, PI3K‐Akt signaling, pathways in cancer, proteoglycans in cancer, progesterone‐mediated oocyte maturation, and others. The molecular docking results showed that BDE‐99, BDE‐153, 5‐OH‐BDE47, 5 ′‐OH‐BDE99, 5‐BDE47 sulfate, and 5 ′‐BDE99 sulfate have a good binding effect with the kernel targets. PBDEs could interfere with the thyroid hormone endocrine through multiple targets and biological pathways, and metabolites demonstrated stronger effects than the prototypes. This research provides a basis for further research on the toxicological effects and molecular mechanisms of PBDEs and their metabolites. Furthermore, the application of network pharmacology to the study of the toxicity mechanisms of environmental pollutants provides a new methodology for environmental toxicology.